Recent TACE RFA. Evaluate for HCC. ABDOMEN:LIVER, BILIARY TRACT: Cirrhotic liver morphology.The segment 5 ablation cavity measures 3.7 x 3.3 cm (series 8/250). No evidence of marginal recurrent or residual disease.The segment 7/8 ablation cavity measures 3.1 x 2.1 cm (series 8/267). Faint enhancement along the anterosuperior aspect of the ablation cavity may be treatment related and is not significantly changed accounting for technical differences.No new suspicious arterial enhancing or washout lesion.Status post cholecystectomy. No biliary ductal dilatation.SPLEEN: Spleen measures 14.7 cm in length without a focal lesion.PANCREAS: No significant abnormality noted.ADRENAL GLANDS: Mild left adrenal nodularity is unchanged.KIDNEYS, URETERS: No significant abnormality noted.RETROPERITONEUM, LYMPH NODES: No enlarged retroperitoneal lymphadenopathy. Likely reactive porta hepatis lymph nodes.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
Stable examination with postablation changes of segment 5 and 7/8 without specific evidence of marginal recurrent or residual disease. Faint enhancement adjacent to the segment 7/8 cavity is unchanged and may be treatment related. Continued follow-up is recommended.